News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,350 Results
Type
Article (40731)
Company Profile (276)
Press Release (647343)
Section
Business (205753)
Career Advice (1991)
Deals (35613)
Drug Delivery (82)
Drug Development (81602)
Employer Resources (167)
FDA (16197)
Job Trends (14906)
News (347596)
Policy (33005)
Tag
Academia (2592)
Africa (729)
Alliances (49922)
Alzheimer's disease (1163)
Approvals (16118)
Arizona (174)
Artificial intelligence (69)
Asia (37665)
Australia (6106)
Bankruptcy (354)
Best Places to Work (11349)
Biosimilars (68)
Biotechnology (197)
C2C Services and Suppliers (79600)
California (1871)
Canada (932)
Cancer (492)
Career advice (1659)
Cell therapy (124)
China (150)
Clinical research (63911)
Collaboration (143)
Colorado (74)
Compensation (80)
Connecticut (74)
COVID-19 (2535)
Cystic fibrosis (74)
Data (305)
Diabetes (83)
Diagnostics (6025)
Drug pricing (65)
Earnings (84019)
Employer resources (142)
Europe (80706)
Events (109160)
Executive appointments (152)
FDA (16422)
Florida (263)
Funding (148)
Gene therapy (94)
GLP-1 (518)
Government (4411)
Healthcare (18796)
Hotbed/Location (485720)
Illinois (254)
Indiana (149)
Infectious disease (2562)
Inflammatory bowel disease (93)
Interviews (307)
IPO (16308)
Job creations (3678)
Job search strategy (1424)
Kansas (94)
Layoffs (399)
Legal (7903)
Lung cancer (113)
Manufacturing (88)
Maryland (411)
Massachusetts (1527)
Medical device (13144)
Medtech (13149)
Mergers & acquisitions (19169)
Metabolic disorders (247)
Michigan (124)
Minnesota (223)
Neuroscience (1309)
New Jersey (584)
New York (596)
NextGen Class of 2024 (6559)
Non-profit (4523)
North Carolina (677)
Northern California (820)
Obesity (146)
Ohio (106)
Opinion (179)
Patents (71)
Pennsylvania (581)
People (56459)
Pharmaceutical (64)
Phase I (19861)
Phase II (28133)
Phase III (21010)
Pipeline (108)
Postmarket research (2575)
Preclinical (8435)
Press Release (71)
Rare diseases (131)
Real estate (6021)
Recruiting (63)
Regulatory (21621)
Research institute (2365)
Resumes & cover letters (347)
South America (1106)
Southern California (758)
Startups (3625)
Texas (240)
United States (8663)
Vaccines (494)
Washington State (255)
Weight loss (126)
Date
Today (124)
Last 7 days (666)
Last 30 days (2405)
Last 365 days (37618)
2024 (26412)
2023 (40468)
2022 (51663)
2021 (56206)
2020 (54557)
2019 (47056)
2018 (35495)
2017 (32608)
2016 (32030)
2015 (38108)
2014 (31822)
2013 (26822)
2012 (29042)
2011 (29744)
2010 (27769)
688,350 Results for "biologics inc nc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
NextCure, Inc. today announced that clinical data from the Phase 1b portion of a Phase 1b/2 study evaluating NC410, a LAIR-2 fusion protein, in combination with pembrolizumab will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
May 30, 2024
·
5 min read
Business
Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company based in Japan, announced that its board of directors has approved plans to invest up to $530 million to build a new, state-of-the-art manufacturing facility in Sanford, North Carolina.
June 10, 2024
·
4 min read
BioCapital
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
NextCure, Inc. (Nasdaq: NXTC) today announced that clinical trial investigator Eric S. Christenson, M.D., Assistant Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, will present a poster on clinical data from the Phase 1b portion of a study evaluating NC410 in combination with pembrolizumab at the American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 – June 4 in Chicago.
April 24, 2024
·
2 min read
Press Releases
NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
September 17, 2024
·
3 min read
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Press Releases
Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
August 6, 2024
·
1 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park
Solvias announced that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C.
May 6, 2024
·
2 min read
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Pharm Country
Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA), has determined that the Biologic License Application (BLA) for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review.
June 20, 2024
·
3 min read
1 of 68,835
Next